Perioperative Management of Hemophilia a Using Recombinant Factor VIII in Patients Undergoing Major or Minor Surgery

Blood - United States
doi 10.1182/blood-2018-99-115755
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Society of Hematology

Related search

AMulticenter Clinical Study of Recombinant Factor VIII (BL-160) in Hemophilia a Patients

Japanese Journal of Thrombosis and Hemostasis
1993English

Perioperative Glucose Management in Patients Undergoing Cardiac Surgery

European Journal of Anaesthesiology
AnesthesiologyPain Medicine
2013English

Elective Surgery on Factor VIII Inhibitor Patients Using Continuous Infusion of Recombinant Activated Factor VII

Thrombosis and Haemostasis
Hematology
2001English

Perioperative Care for Adolescents Undergoing Major Surgery

Anesthesia and Analgesia
AnesthesiologyPain Medicine
2019English

Real-World Health Care Expenditure in Hemophilia a Patients Using Standard and Extended Half-Life Recombinant Factor VIII Products

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2017English

Perioperative Management of Patients on Clopidogrel (Plavix) Undergoing Major Lung Resection

Annals of Thoracic Surgery
Respiratory MedicinePulmonaryCardiovascular MedicineSurgeryCardiology
2011English

Study on Oral Hemorrhagic Management in Patients With Blood Disease. Report 22. A Case of Hemophilia a Receiving Recombinant Human Factor VIII.

Japanese Journal of Oral & Maxillofacial Surgery
1995English

Perioperative Immunonutrition in Patients Undergoing Cancer Surgery

Archives of Surgery
1999English

Statins and Incidence of Perioperative Mortality in Patients Undergoing Major Noncardiac Vascular Surgery * Response

Circulation
Cardiovascular MedicinePhysiologyCardiology
2003English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy